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QUESTIONS
1. Describe the various types of mastocytosis.
2. What was the rationale for this study?
3. Explain the methods employed.
4. What were the results?
5. What were the conclusions and implications of the study?
Mastocytosis can affect both children and adults, and, depending on age at onset, 
its manifestations and prog nosis may differ. Childhood mastocytosis generally has 
a good prognosis and typically presents in children under 2 years of age. Pediatric 
mastocytosis tends to regress spontaneously, is rarely associated with hematologic 
disorders, and rarely affects organs other than skin. Most patients improve substan-
tially, or their disease resolves completely before the onset of puberty (Kiszewski 
et al., 2004; Ben-Amitai et al., 2005). Adult-onset mastocytosis can be severe, is com-
monly considered incurable, and may be associated with systemic involvement of 
multiple organ systems. Adult-onset masto cytosis may also be associated with clon-
al hematologic non-mast-cell-lineage diseases, such as myelo dysplastic and myelo-
proliferative disorders. It can lead to rare mast cell leukemia, carrying a high risk of 
mortality (Valent et al., 2003). The adult-onset form of the disease is associated with 
c-KIT mutations, mostly in exon 17 (D816V).
Several small studies have found different frequencies of c-KIT mutations in patients with childhood-onset 
mastocytosis, and debate has focused on whether this form of mastocytosis is a reactive or a clonal disease (Longley 
et al., 1996; Buttner et al., 1998; Verzijl et al., 2007). For this reason, Bodemer and colleagues studied a relatively large 
cadre of patients with childhood mastocytosis (2010, this issue). These patients were enrolled at multiple sites, and each 
patient had a positive Darier’s sign (with their disease confirmed by histopathology). The investigators examined the 
patients’ skin biopsies for mutations in codon 816 (exon 17, D816V) and other c-KIT mutations. They observed a high rate 
of mutations; 42% were found in D816V and 44% were found outside exon 17. Half of these mutations were encoded in 
an unexpected location: exons 8 and 9. All the mutations identified were somatic, and all caused activation of c-KIT.
Through the following questions, we examine this article in greater detail. For brief answers, please refer to the 
supplementary material online.
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